• 1
    Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the asthma insights and reality in Europe (AIRE) study. Eur Respir J 2000;16: 802807.
  • 2
    Bateman ED, Frith LF, Braunstein GL. Achieving guideline-based asthma control: does the patient benefit? Eur Respir J 2002;20: 588595.
  • 3
    Holt S, Kljakovic M, Reid J. Asthma morbidity, control and treatment in New Zealand: results of the Patient Outcomes Management Survey (POMS). N Z Med J 2001;116: U436.
  • 4
    Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJH, Pauwels RA et al. Can guideline-defined asthma control be achieved? The gaining optimal asthma control study. Am J Respir Crit Care Med 2004;170: 836844.
  • 5
    Global Initiative for Asthma (GINA). Pocket Guide for Asthma Management and Prevention. Publication No. 95–3659-B. Bethesda: National Institutes for Health, National Heart, Lung and Blood Institute, 1998.
  • 6
    National Institute for Clinical Excellence (NICE). Guide to the Methods of Technology Assessment. London: NICE, 2004, available at: (Accessed 29 November 2005).
  • 7
    Agresti A. An Introduction to Categorical Data Analysis. New York: John Wiley & Sons, 1996.
  • 8
    Armitage P, Berry G. Statistical Methods in Medical Research, 3rd edn. Oxford: Blackwell Scientific Publications, 1994.
  • 9
    Chan YH. Biostatistics 305. Multinomial logistic regression. Singapore Med J 2005;46: 259268.
  • 10
    Curtis L, Netten A. Unit Costs of Health and Social Care, 12 edn. Canterbury: Personal and Social Services Research Unit, University of Kent, 2004, available at: (Accessed 29 November 2005).
  • 11
    Drummond MF, O'Brien B, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes, 2nd edn. Oxford: Oxford University Press, 1997.
  • 12
    Juniper EF, Guyatt GH, Epstein RS, Ferie PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health-related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992;47: 7683.
  • 13
    Efron B, Tibshirani R. An Introduction to the Bootstrap. New York: Chapman & Hall, 1993.
  • 14
    Briggs AH, Wonderling DE, Mooney CZ. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ 1997;6: 327340.
  • 15
    Devlin N, Parkin D. Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis. Health Econ 2004;13: 437452.
  • 16
    Rawlins MD, Culyer AJ. National Institute for Clinical Excellence and its value judgments. Br Med J 2004;329: 224227.